Lawrence G. Hamel
2018
In 2018, Lawrence G. Hamel earned a total compensation of $688.6K as Chief Development Officer at AcelRx Pharmaceuticals, a 16% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $119,534 |
|---|---|
| Option Awards | $216,558 |
| Salary | $341,525 |
| Other | $11,000 |
| Total | $688,617 |
Hamel received $341.5K in salary, accounting for 50% of the total pay in 2018.
Hamel also received $119.5K in non-equity incentive plan, $216.6K in option awards and $11K in other compensation.
Rankings
In 2018, Lawrence G. Hamel's compensation ranked 10,779th out of 14,244 executives tracked by ExecPay. In other words, Hamel earned more than 24.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,779 out of 14,244 | 24th |
Division Manufacturing | 4,341 out of 5,762 | 25th |
Major group Chemicals And Allied Products | 1,637 out of 2,125 | 23rd |
Industry group Drugs | 1,386 out of 1,814 | 24th |
Industry Pharmaceutical Preparations | 1,063 out of 1,388 | 23rd |
Pay ratio
| Lawrence G. Hamel's Pay | $688,617 |
|---|---|
| Median Employee's Pay | $328,891 |
| Pay Ratio | 2to 1 |
In 2018, the annual total compensation of Lawrence G. Hamel was $688,617.
The annual total compensation of the median employee at AcelRx Pharmaceuticals was $328,891.
The ratio of Lawrence G. Hamel's pay to the pay of median employee was therefore 2 to one.
Source: SEC filing on May 14, 2019.
Hamel's colleagues
We found four more compensation records of executives who worked with Lawrence G. Hamel at AcelRx Pharmaceuticals in 2018.